Biotransformation pathways of ginsenoside Rb1 to compound K by β-glucosidases in fungus Paecilomyces Bainier sp 229

被引:107
作者
Yan, Qin [1 ]
Zhou, Wei [1 ]
Shi, XunLong [1 ]
Zhou, Pei [1 ]
Ju, DianWen [1 ]
Feng, MeiQing [1 ]
机构
[1] Fudan Univ, Sch Pharm, Dept Biosynthet Drugs, Shanghai 201203, Peoples R China
关键词
Ginsenoside Rb1; Metabolite; Biotransformation pathway; beta-Glucosidase; INTESTINAL BACTERIA; SAPONINS; PURIFICATION; METABOLISM; INHIBITION; APOPTOSIS; SP-229; RATS;
D O I
10.1016/j.procbio.2010.06.007
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
070307 [化学生物学]; 071010 [生物化学与分子生物学];
摘要
Ginsenoside Rb1 is the most abundant ginsenoside in Panax (ginseng). The hydrolysis of this ginsenoside produces compound K, the biologically active ginsenoside of ginseng. We previously identified a fungus Paecilomyces Bainier sp. 229 (sp. 229), which can efficiently convert ginsenoside Rb1 to compound K. In this report, the ginsenoside hydrolyzing beta-glucosidases were isolated from sp. 229 and the pathway of the biotransformation of ginsenoside Rb1 to compound K by sp. 229 was investigated. Based on reverse-phase HPLC and TLC analysis, we found the main metabolic pathway is as follows: ginsenoside Rb1 -> ginsenoside Rd -> ginsenoside F2 -> compound K. Moreover, the results showed that there were other metabolic pathways: ginsenoside Rb1 -> ginsenoside XVII -> ginsenoside F2 -> compound K and ginsenoside Rb1 -> ginsenoside Rg3 -> ginsenoside Rh2. These processes would allow the specific bioconversion of ginsenoside Rb1 to various ginsenosides using an appropriate combination of specific microbial enzymes. Crown Copyright (C) 2010 Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:1550 / 1556
页数:7
相关论文
共 28 条
[1]
Metabolism of ginsenoside Re by human intestinal microflora and its estrogenic effect [J].
Bae, EA ;
Shin, JE ;
Kim, DH .
BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2005, 28 (10) :1903-1908
[2]
Metabolism of ginsenoside Rc by human intestinal bacteria and its related antiallergic activity [J].
Bae, EA ;
Choo, MK ;
Park, EK ;
Park, SY ;
Shin, HY ;
Kim, DH .
BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2002, 25 (06) :743-747
[3]
CACAO T, 1998, BIOL PHARM BULL, V21, P245
[4]
Conversion of major ginsenoside Rb1 to ginsenoside F2 by Caulobacter leidyia [J].
Cheng, Le-Qin ;
Kim, Myung Kyum ;
Lee, Jun-Won ;
Lee, Youn-Jin ;
Yang, Deok-Chun .
BIOTECHNOLOGY LETTERS, 2006, 28 (14) :1121-1127
[5]
DEGRADATION OF GINSENG SAPONINS UNDER MILD ACIDIC CONDITIONS [J].
HAN, BH ;
PARK, MH ;
HAN, YN ;
WOO, LK ;
SANKAWA, U ;
YAHARA, S ;
TANAKA, O .
PLANTA MEDICA, 1982, 44 (03) :146-149
[6]
Proof of the mysterious efficacy of ginseng: Basic and clinical trials: Metabolic activation of ginsenoside: Deglycosylation by intestinal bacteria and esterification with fatty acid [J].
Hasegawa, H .
JOURNAL OF PHARMACOLOGICAL SCIENCES, 2004, 95 (02) :153-157
[7]
Transformation of ginsenosides Rb1 and Re from Panax ginseng by food microorganisms [J].
Chi, H ;
Ji, GE .
BIOTECHNOLOGY LETTERS, 2005, 27 (11) :765-771
[8]
Inhibition by ginsenoside Rg(3) of bombesin-enhanced peritoneal metastasis of intestinal adenocarcinomas induced by azoxymethane in Wistar rats [J].
Iishi, H ;
Tatsuta, M ;
Baba, M ;
Uehara, H ;
Nakaizumi, A ;
Shinkai, K ;
Akedo, H ;
Funai, H ;
Ishiguro, S ;
Kitagawa, I .
CLINICAL & EXPERIMENTAL METASTASIS, 1997, 15 (06) :603-611
[9]
Enzymatic preparation of ginsenosides Rg2, Rh1, and F1 from protopanaxatriol-type ginseng saponin mixture [J].
Ko, SR ;
Choi, KJ ;
Uchida, K ;
Suzuki, Y .
PLANTA MEDICA, 2003, 69 (03) :285-286
[10]
CLEAVAGE OF STRUCTURAL PROTEINS DURING ASSEMBLY OF HEAD OF BACTERIOPHAGE-T4 [J].
LAEMMLI, UK .
NATURE, 1970, 227 (5259) :680-+